Table 4.

Role of Steroids in Management of Pain in Type 3 AIP

Characteristics	All patients with abdominal pain (n = 86)	Patients that received steroids (n = 43)	Patients who did not receive steroids (n = 43)	P Value
Duration of abdominal pain (d)				.50
0–14	67 (78%)	33 (76.7%)	34 (79%)
15–30	13 (15%)	8 (18.6%)	5 (12%)
> 30	6 (7%)	2 (4.6%)	4 (9%)
Abdominal pain severity				.19
0–3	54 (63%)	31 (72%)	23 (53%)
4–6	9 (10%)	3 (7%)	6 (14%)
7–10	23 (27%)	9 (21%)	14 (33%)
Time (days) to resume ICI				.62
< 30 d	5 (6%)	3 (7%)	2 (4.6%)
≥ 30 d	13 (15%)	5 (12%)	8 (18.6%)
Did not resume ICI	68 (79%)	35 (81%)	33 (76.7%)
Recurrence of type 3 AIP				.56
Yes	3 (3.5%)	2 (5%)	1 (2%)
No	83 (96.5%)	41 (95%)	42 (98%)